Advanced Search

 

Study ID Status Title Patient Level Data
APV40003 Completed Safety and efficacy of GW433908 in antiretroviral combination therapy in patients with HIV infection
APV40004 Completed Expanded access programme of Fosamprenavir (GW433908) /ritonavir for patients infected by HIV.
APV40005 Completed An open-label phase III study to provide access to fosamprenavir and to assess the long term safety and tolerability of fosamprenavir containing regimens in HIV Infected patients with limited treatment options
APV40006 Completed GW433908 Open Label Study for Subjects with HIV who are Treatment Experienced, on a Failing Regimen or Intolerant to Current Therapy and Sensitive to GW433908
APVF3002 Completed Multicentre, open label, pilot study to evaluate genotypic sensitivity score of fosamprenavir (700mg) in combination with ritonavir (100mg) twice daily, in human immunodeficiency virus (HIV) infected patients with virological escape after first line treatment with a protease inhibitor (PI).
APVF3031 Completed Multicentre, randomized, comparative, open, pilot study to assess efficacy and safety of a treatment with two protease inhibitors (GW433908 + Indinavir [IDV, Crixivan]) boosted by ritonavir in combination with nucleoside reverse transcriptase inhibitor (NRTI) in experienced HIV-1 infected subjects.
APVF3032 Completed Efficacy and pharmacologic evaluation at week 4 of fosamprenavir/ritonavir BID in HIV, pretreated patients switching from amprenavir/ritonavir with controlled plasma viremia.
AR3106116 Completed Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) after Abdominal Surgery
AR3106333 Completed Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism after Elective Total Hip Replacement Surgery
AR3106335 Completed Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism after Hip Fracture Surgery
ARA102198 Completed A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arthritis Study Listed on ClinicalStudyDataRequest.com
ARG-402 Completed Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis
ARI10015 Completed An Evaluation of the Absolute Bioavailability of GI198745 (dutasteride) Soft Gelatin Capsules Compared to GI198745 (dutasteride) Intravenous Solution in Healthy Volunteers.
ARI10016 Completed A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of GI198645 (dutasteride) Dose for 21 Days on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Volunteers.
ARI10017 Completed A study to investigate the effect of GI198745 (dutasteride) on the pharmacokinetics of digoxin in healthy male volunteers.
ARI10018 Completed An Evaluation of the Bioequivalence of GI198745/dutasteride Soft Gelatin Capsules Compared to GI198745/dutasteride Cross-linked Gelatin Capsules in Healthy Male Volunteers.
ARI10019 Completed A double-blind, placebo-controlled, randomized, parallel group study to investigate the changes in corrected QT interval following repeat oral doses of GI198745 in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
ARI10023 Completed A double blind, randomized and placebo-controlled parallel group study to evaluate the safety and pharmacokinetics/pharmacodynamics of a single oral 0.5mg dose of dutasteride in healthy Korean male volunteers.
ARI105326 Completed Clinical Evaluation of dutasteride in Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparative Study of GI198745 (dutasteride) in Subjects with Benign Prostatic Hyperplasia.
ARI108898 Completed A randomized, double-blind, placebo-controlled, six-month parallel-group study to assess efficacy and safety of dutasteride 0.5mg once daily in Chinese patients with Benign Prostatic Hyperplasia (BPH), followed by a 12-month open-label treatment phase
ARI109882 Completed An Open-Label, Randomized, Single Dose Three-Period Partial Crossover Study to Determine the Bioequivalence and Food Effect of a Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.4mg) Compared to Concomitant Dosing of AVODART™ 0.5mg and Flomax 0.4mg Commercial Capsules in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
ARI109924 Completed A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men with Prostate Cancer and Biochemical Failure (PSA increase) after Radical Therapy with Curative Intent
ARI111402 Completed An open label, randomized, repeat dose, 3 period crossover study to determine the bioequivalence of 3 different formulations of tamsulosin at steady state in healthy male volunteers Study Listed on ClinicalStudyDataRequest.com
ARI19033 Completed An open label, single dose, randomised, three period crossover study to investigate the relative bioavailability of dutasteride softgel vs. dutasteride tablet and dutasteride softgel vs. dutasteride capsule in healthy male volunteers Study Listed on ClinicalStudyDataRequest.com
ARI20005 Completed A multi-centre, double-blind, stratified randomized, placebo-controlled, parallel group comparative, dose finding study of GI198745 in patients with benign prostatic hyperplasia

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.